Dicyclomine Safety in Small Bowel Obstruction

Rationale for Avoiding Dicyclomine in SBO

Antimuscarinics reduce gastrointestinal motility, which is counterproductive in SBO where the goal is to restore normal peristalsis and bowel function 1, 2
Dicyclomine has antimuscarinic properties that directly relax smooth muscle, potentially worsening the obstruction by further reducing propulsive activity 1, 2
The American Gastroenterological Association implies that antimuscarinics like dicyclomine are contraindicated in mechanical bowel obstruction, as they can worsen intestinal dysmotility 1, 2

The World Journal of Emergency Surgery recommends nil per os (NPO) status, intravenous fluid resuscitation, electrolyte correction, and prevention of aspiration as cornerstone management for non-operative SBO 3, 5
The standard management does not include antimuscarinics, as they are contraindicated in acute mechanical obstruction 3, 4, 5

Antimuscarinics like dicyclomine are indicated for chronic intestinal dysmotility with pain from smooth muscle spasm, which is a different clinical scenario than acute mechanical obstruction 1, 2

NGT decompression addresses proximal accumulation of fluid and gas but does not resolve the underlying obstruction, and reducing motility with antimuscarinics could impair resolution 3
Non-operative management success depends on restoration of bowel function, not suppression of it, with a success rate of 70-90% of cases 3, 4, 5

Opioid analgesics are appropriate for pain management in SBO, but high doses should be avoided as they could worsen ileus 1, 2, 5
Antiemetics that don't increase motility, such as ondansetron, are preferred for nausea and vomiting management 1, 2, 5

The American College of Surgeons recommends monitoring for signs requiring surgery, such as peritonitis, strangulation, ischemia, or failure of conservative management after 72 hours 3, 4, 5
Delays in surgical consultation when indicated should be avoided, as they increase morbidity and mortality 3